![]() |
市場調查報告書
商品編碼
1898065
機械血栓切除裝置市場規模、佔有率和成長分析(按產品類型、應用、最終用戶和地區分類)—產業預測(2026-2033 年)Mechanical Thrombectomy Devices Market Size, Share, and Growth Analysis, By Product Type (Aspiration Catheters, Stent Retrievers), By Application (Ischemic Stroke, Pulmonary Embolism (PE)), By End-user, By Region - Industry Forecast 2026-2033 |
||||||
全球機械血栓切除裝置市場規模預計在 2024 年達到 17.7 億美元,從 2025 年的 19 億美元成長到 2033 年的 32.8 億美元,在預測期(2026-2033 年)內複合年成長率為 7.1%。
由於中風和血管疾病的發生率不斷上升,全球機械取栓設備市場正經歷強勁成長。微創醫療的趨勢日益顯著,這對取栓技術的發展產生了正面影響。機械取栓術是一種創傷較小的治療選擇,適用於血栓引起的缺血性中風等疾病,深受患者和醫療機構的青睞,因為他們希望透過這種手術改善治療效果,同時減少創傷並促進康復。推動市場發展的關鍵因素包括技術創新、人口老化加劇以及醫療基礎設施的持續改善。主要企業正積極致力於產品研發、臨床試驗和策略合作,以鞏固其市場地位;然而,成本限制和認知度不足等挑戰依然存在。對有效取栓解決方案的需求依然強勁,支撐著市場的持續成長。
全球機械血栓切除裝置市場促進因素
推動全球機械取栓裝置市場成長的關鍵因素之一是中風(尤其是缺血性中風)發生率的上升。這些先進的裝置在有效清除阻塞動脈中的血栓方面發揮關鍵作用,從而降低中風相關殘疾和死亡的風險。隨著世界人口老化以及高血壓、糖尿病和肥胖等相關危險因子的盛行率不斷上升,預計對機械取栓手術的需求將大幅增加。這一趨勢凸顯了這些裝置在改善患者預後和提升公眾健康整體的重要性。
限制全球機械血栓切除裝置市場的因素
機械取栓裝置的高成本對其廣泛應用構成重大挑戰。除了裝置本身的成本外,手術相關的綜合費用,包括住院和術後護理,都給醫療系統、保險公司和患者帶來了經濟負擔。這種經濟壓力限制了患者獲得這些重要療法的機會,並最終可能阻礙機械血栓除去裝置在臨床實踐中的廣泛應用。因此,這些技術的潛在益處可能無法充分發揮,從而限制了其在血栓事件治療中對患者預後的影響。
全球機械血栓切除裝置市場趨勢
受技術進步和產品創新的推動,全球機械取栓裝置市場呈現強勁成長動能。製造商致力於開發高效、精準且微創的取栓解決方案,以改善患者預後。這一趨勢包括改進裝置設計、應用先進成像技術以及整合機器人和導航系統,從而提高手術的有效性和安全性。隨著對有效中風治療的醫療需求不斷成長,這些創新不僅簡化了流程,也順應了個人化醫療的趨勢,從而為該細分市場的持續成長和日益激烈的市場競爭奠定了基礎。
Global Mechanical Thrombectomy Devices Market size was valued at USD 1.77 Billion in 2024 and is poised to grow from USD 1.9 Billion in 2025 to USD 3.28 Billion by 2033, growing at a CAGR of 7.1% during the forecast period (2026-2033).
The global market for mechanical thrombectomy devices is experiencing robust growth, driven by the increasing prevalence of stroke and vascular diseases. There is a notable shift towards minimally invasive healthcare practices, which is positively impacting thrombectomy techniques. Mechanical thrombectomy serves as a less invasive treatment alternative for conditions like ischemic stroke due to blood clots, appealing to both patients and healthcare providers seeking procedures that reduce trauma and accelerate recovery while delivering improved outcomes. Key market drivers include technological innovations, a growing elderly population, and advancements in healthcare infrastructure. Leading companies are actively focusing on product development, clinical trials, and strategic partnerships to strengthen their market positions, although challenges such as cost limitations and lack of awareness persist. The demand for effective clot removal solutions remains strong, fueling continued market growth.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Mechanical Thrombectomy Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Mechanical Thrombectomy Devices Market Segments Analysis
Global Mechanical Thrombectomy Devices Market is segmented by Product Type, Application, End-user and region. Based on Product Type, the market is segmented into Aspiration Catheters, Coil Retrievers, Stent Retrievers, and Other Devices. Based on Application, the market is segmented into Ischemic Stroke, Pulmonary Embolism (PE) and Deep Vein Thrombosis (DVT). Based on End-user, the market is segmented into Hospitals, Ambulatory Surgical Centers and Specialty Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Mechanical Thrombectomy Devices Market
One of the key factors propelling the growth of the global mechanical thrombectomy devices market is the increasing occurrence of strokes, especially ischemic strokes. These advanced devices play a crucial role in efficiently extracting blood clots from obstructed arteries, thereby mitigating the potential for disability and mortality linked to strokes. As the global population ages and the prevalence of associated risk factors, such as hypertension, diabetes, and obesity, grows, there is an anticipated surge in the demand for mechanical thrombectomy procedures. This trend highlights the importance of these devices in improving patient outcomes and overall public health.
Restraints in the Global Mechanical Thrombectomy Devices Market
The widespread adoption of mechanical thrombectomy devices faces significant challenges due to their high costs. The expenses associated with the devices, along with the comprehensive costs related to the procedures, such as hospitalization and post-operative care, create financial hurdles for health systems, insurance providers, and patients. This financial burden can restrict access to these critical interventions, ultimately hindering the growth and utilization of mechanical thrombectomy devices in clinical practice. As a result, the potential benefits of these technologies may not be fully realized, limiting their impact on patient outcomes in the treatment of thrombotic events.
Market Trends of the Global Mechanical Thrombectomy Devices Market
The Global Mechanical Thrombectomy Devices market is witnessing a robust trend driven by technological advancements and product innovation. Manufacturers are focusing on creating highly efficient, precise, and minimally invasive thrombectomy solutions that improve patient outcomes. This trend encompasses enhancements in device design, the incorporation of advanced imaging technologies, and the integration of robotic or navigation systems that elevate procedural effectiveness and safety. As healthcare demand for effective stroke treatments grows, these innovations not only streamline processes but also align with a broader shift towards personalized medicine, positioning the sector for sustained growth and enhanced market competitiveness.